Dr. Lofgren is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
909 Fulton St SE
Minneapolis, MN 55455Phone+1 612-672-7422
Education & Training
- University of MinnesotaFellowship, Infectious Disease, 2013 - 2015
- Emory University School of MedicineResidency, Internal Medicine, 2010 - 2013
- Duke University School of MedicineClass of 2010
Certifications & Licensure
- MN State Medical License 2013 - 2024
- GA State Medical License 2012 - 2013
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Clinical Trials
- Neuroinflammation and Modulating Factors in Depression and HIV Start of enrollment: 2021 Feb 01
Roles: Principal Investigator, Contact
- Welcoming by Design Pilot: Reducing Structural Stigma by Changing Clinic Systems and Architectural Design Start of enrollment: 2024 Jul 30
Roles: Contact
- Supervised Treadmill Intervention to Reduce Inflammation and Depression Through Exercise in HIV: The STRIDE Pilot Study Start of enrollment: 2024 Jul 01
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- 859 citationsA Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19.David R. Boulware, Matthew F Pullen, Ananta S. Bangdiwala, Katelyn A Pastick, Sarah M Lofgren
The New England Journal of Medicine. 2020-06-03 - 36 citationsSymptoms of COVID-19 Outpatients in the United StatesMatthew F Pullen, Caleb P Skipper, Katherine Huppler Hullsiek, Ananta S Bangdiwala, Katelyn A Pastick
Open Forum Infectious Diseases. 2020-07-01 - 6 citationsSystematic review of sex differences in the relationship between hormones and depression in HIV.Morgan C Turk, Caitlin J Bakker, Sade M Spencer, Sarah M Lofgren
Psychoneuroendocrinology. 2022-04-01
Press Mentions
- Safety of Hydroxychloroquine Among Outpatient Clinical Trial Participants for COVID-19October 19th, 2020
- Symptoms of COVID-19 Outpatients in the United StatesJune 30th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: